financetom
Business
financetom
/
Business
/
Apple accused of making false claims about iPhone X series
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple accused of making false claims about iPhone X series
Dec 16, 2018 5:29 AM

A lawsuit filed in a US court has accused Apple of making false claims about the screen sizes and pixel counts of the displays in its iPhone X series, CNET reported.

The suit filed on Friday in the District Court of Northern California alleges that the Cupertino, California-headquartered tech giant lied about the screen sizes of iPhone X, iPhone XS and iPhone XS Max devices by counting non-screen areas like the notch and corners.

The two plaintiffs who filed the suit are seeking class action status, according to the report.

The suit alleges that Apple is falsely marketing the new line of iPhones as "all screen".

For example, the screen size of iPhone X is "only about 5.6875 inches", and not 5.8 inches as claimed by Apple, the complaint stated.

The plaintiffs also allege that the iPhone X series phones have lower screen resolution than advertised, the CNET report said on Saturday.

Apple was sued over its products earlier also. A lawsuit filed in June alleged that the screen of Apple Watch has a tendency to "crack, shatter or detach from the body of the watch."

First Published:Dec 16, 2018 2:29 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Northwest Bancshares' Q4 Adjusted Earnings, Revenue Rise
Northwest Bancshares' Q4 Adjusted Earnings, Revenue Rise
Jan 24, 2025
07:49 AM EST, 01/24/2025 (MT Newswires) -- Northwest Bancshares ( NWBI ) reported Q4 adjusted earnings Friday of $0.27 per diluted share, up from $0.24 a year earlier. Analysts polled by FactSet expected $0.25. Revenue for the quarter ended Dec. 31, expressed as the sum of net interest income and total noninterest income, was $154.3 million, up from $135.5 million...
Merck, Eisai Gastroesophageal Cancer Combo Therapy Meets One Primary Endpoint in Trial
Merck, Eisai Gastroesophageal Cancer Combo Therapy Meets One Primary Endpoint in Trial
Jan 24, 2025
07:47 AM EST, 01/24/2025 (MT Newswires) -- Merck ( MRK ) and Eisai said Friday that results from a phase 3 trial of Keytruda (pembrolizumab) and Lenvima (lenvatinib) in combination with chemotherapy as a first-line treatment of patients with locally advanced inoperable or metastatic gastroesophageal adenocarcinoma showed statistically significant improvement in progression-free survival, a primary endpoint. The potential treatment for...
HCA Healthcare' Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Guidance
HCA Healthcare' Q4 Adjusted Earnings, Revenue Rise; Provides 2025 Guidance
Jan 24, 2025
07:49 AM EST, 01/24/2025 (MT Newswires) -- HCA Healthcare ( HCA ) reported Q4 adjusted earnings Friday of $6.22 per diluted share, up from $5.90 a year earlier. Analysts polled by FactSet expected $6.13. Revenue for the quarter ended Dec. 31 was $18.29 billion compared with $17.30 billion a year earlier. Analysts surveyed by FactSet expected $18.23 billion. The company...
Scotiabank Comments on Canadian Dollar
Scotiabank Comments on Canadian Dollar
Jan 24, 2025
07:48 AM EST, 01/24/2025 (MT Newswires) -- The Canadian dollar (CAD or loonie) has struggled in the wake of November's United States presidential election, noted Scotiabank. President Trump's threat of massive and universal tariffs on Canadian exports to the U.S. has weakened sentiment materially, given the extensive economic harm that tariffs would do, said the bank. Scotiabank assumes a more...
Copyright 2023-2026 - www.financetom.com All Rights Reserved